Literature DB >> 22851612

Evaluation of cognitive impairment by the Montreal cognitive assessment in patients with aneurysmal subarachnoid haemorrhage: prevalence, risk factors and correlations with 3 month outcomes.

George Kwok Chu Wong1, Sandy Lam, Karine Ngai, Adrian Wong, Vincent Mok, W S Poon.   

Abstract

OBJECTIVE: Identification of patients with aneurysmal subarachnoid haemorrhage (aSAH) with cognitive impairment is important for patient management (medical treatment, cognitive rehabilitation and social arrangements). The Montreal cognitive assessment (MoCA) is currently recommended over the mini-mental state examination (MMSE) by the U.S. National Institute of Neurological Disorder, in the chronic post-stroke setting. We hypothesised that the MoCA has a better correlation with functional outcome at 3 months than the MMSE.
METHODS: We carried out a prospective observational study in Hong Kong over a 2 year period, recruiting patients aged 21-75 years with aSAH admitted within 96 h of ictus. The assessments included the modified Rankin Scale, Lawton Instrumental Activity of Daily Living (IADL), Short Form-36, MoCA and MMSE at 3 months after ictus. Analyses were carried out to compare MoCA with MMSE.
RESULTS: 90 patients completed the 3 month assessments. Cognitive impairment (MoCA <26) was determined in 73% of patients at 3 months. Delayed cerebral infarction explained the 31-38% variance in cognitive outcomes (MMSE and MoCA) at 3 months. MoCA demonstrated good discrimination of favourable neurological and IADL outcomes similar to the MMSE in receiver operating characteristics curve analyses.
CONCLUSIONS: MoCA defined cognitive impairment was common at 3 months after aSAH and MoCA correlated with functional outcomes similar, but not superior, to the MMSE. The study is registered at ClinicalTrials.gov of the US National Institutes of Health (NCT01038193).

Entities:  

Mesh:

Year:  2012        PMID: 22851612     DOI: 10.1136/jnnp-2012-302217

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  26 in total

1.  Neutrophil depletion after subarachnoid hemorrhage improves memory via NMDA receptors.

Authors:  Jose Javier Provencio; Valerie Swank; Haiyan Lu; Sylvain Brunet; Selva Baltan; Rohini V Khapre; Himabindu Seerapu; Olga N Kokiko-Cochran; Bruce T Lamb; Richard M Ransohoff
Journal:  Brain Behav Immun       Date:  2016-02-09       Impact factor: 7.217

2.  RAR-Related Orphan Receptor Gamma T (RoRγt)-Related Cytokines Play a Role in Neutrophil Infiltration of the Central Nervous System After Subarachnoid Hemorrhage.

Authors:  A P Coulibaly; W T Gartman; V Swank; J A Gomes; L Ruozhuo; J DeBacker; J J Provencio
Journal:  Neurocrit Care       Date:  2020-08       Impact factor: 3.210

3.  Author's reply to Page: "Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept".

Authors:  Edward Tobinick
Journal:  CNS Drugs       Date:  2013-05       Impact factor: 5.749

4.  Prioritization and Timing of Outcomes and Endpoints After Aneurysmal Subarachnoid Hemorrhage in Clinical Trials and Observational Studies: Proposal of a Multidisciplinary Research Group.

Authors:  Martin N Stienen; Johanna M Visser-Meily; Tom A Schweizer; Daniel Hänggi; R Loch Macdonald; Mervyn D I Vergouwen
Journal:  Neurocrit Care       Date:  2019-06       Impact factor: 3.210

5.  Montreal Cognitive Assessment 5-minute protocol is a brief, valid, reliable, and feasible cognitive screen for telephone administration.

Authors:  Adrian Wong; David Nyenhuis; Sandra E Black; Lorraine S N Law; Eugene S K Lo; Pauline W L Kwan; Lisa Au; Anne Y Y Chan; Lawrence K S Wong; Ziad Nasreddine; Vincent Mok
Journal:  Stroke       Date:  2015-02-19       Impact factor: 7.914

6.  Early MoCA-assessed cognitive impairment after aneurysmal subarachnoid hemorrhage and relationship to 1-year functional outcome.

Authors:  George Kwok Chu Wong; Sandy Wai Lam; Adrian Wong; Vincent Mok; Deyond Siu; Karine Ngai; Wai Sang Poon
Journal:  Transl Stroke Res       Date:  2013-09-07       Impact factor: 6.829

7.  Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept.

Authors:  Edward Tobinick; Nancy M Kim; Gary Reyzin; Helen Rodriguez-Romanacce; Venita DePuy
Journal:  CNS Drugs       Date:  2012-12       Impact factor: 5.749

8.  Severe cognitive impairment in aneurysmal subarachnoid hemorrhage: Predictors and relationship to functional outcome.

Authors:  Joseph R Geraghty; Melissa N Lara-Angulo; Milen Spegar; Jenna Reeh; Fernando D Testai
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-06-20       Impact factor: 2.136

9.  Cognitive screening in patients with intracranial tumors: validation of the BCSE.

Authors:  Juliane Becker; Elisabeth Steinmann; Maria Könemann; Sonja Gabske; Hubertus Maximilian Mehdorn; Michael Synowitz; Gesa Hartwigsen; Simone Goebel
Journal:  J Neurooncol       Date:  2016-02-01       Impact factor: 4.130

10.  Changes in Montreal Cognitive Assessment Scores Over Time.

Authors:  Kamini Krishnan; Heidi Rossetti; Linda S Hynan; Kirstine Carter; Jed Falkowski; Laura Lacritz; C Munro Cullum; Myron Weiner
Journal:  Assessment       Date:  2016-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.